Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-23

FDA Approved: SYMPROIC — Original Application (BioDelivery Sciences International Inc)

View source ↗

Summary

The FDA approved Symproic (naldemedine) from BioDelivery Sciences International, granting original NDA approval NDA208854 for the treatment of opioid-induced co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SYMPROIC (NALDEMEDINE)

Snippet

ORIG AP for SYMPROIC (NALDEMEDINE)